Do Testosterone Boosters Actually Work?

Why It Matters

Because most testosterone boosters are ineffective or unsafe, consumers risk health complications and wasted money, while clinicians must guide patients toward evidence‑based therapies.

Key Takeaways

• Majority of testosterone boosters lack any published efficacy data
• Up to 12% contain undisclosed synthetic steroids, posing health risks
• Some products actually lower testosterone, contrary to claims
• Contamination can cause adrenal issues like Cushing’s syndrome
• Clinicians should prioritize safety, source verification, and alternative treatments

Summary

The video scrutinizes the efficacy and safety of over‑the‑counter testosterone boosters, featuring a physician who blends research findings with real‑world clinical anecdotes.

A 2018 JAMA analysis revealed that 62% of these supplements have no published data supporting their claims, while 10% actually contain evidence of lowering testosterone. A 2020 review of more than 50 products found 18% ineffective, and 12% adulterated with undisclosed synthetic steroids. Independent studies on popular ingredients such as D‑aspartic acid and ZMA showed no benefit, with one D‑aspartic acid trial reporting a significant drop in total and free testosterone.

The physician recounts patients whose supplements were contaminated with anabolic or catabolic steroids, leading to extreme testosterone spikes, adrenal suppression, and even Cushing‑like symptoms. He also highlights the ZMA study authored by Victor Conte—a patent holder and former BALCO figure—underscoring conflicts of interest in the limited positive research.

The overarching message urges clinicians and consumers to treat testosterone boosters with skepticism, verify product sourcing, and address underlying issues like sleep apnea or nutritional deficiencies instead of relying on ineffective, potentially harmful supplements.

Original Description

Jordan and Austin unpack three independent lines of evidence on testosterone booster supplements: a 2018 JAMA review showing 62% have zero published data, a 2020 review showing 12% are adulterated with undisclosed steroids, and the ironic D-aspartic acid finding where the booster actually decreased testosterone. The ZMA/Victor Conte/Balco story delivers a memorable proof point. Austin closes with how he actually handles a patient who walks in already taking a booster — safety assessment, goals, and harm reduction. The clinical perspective is what makes this more than a supplement takedown.

Timestamps

00:03:09 Bridge the prescribing system is broken — what about supplements?

00:03:37 JAMA 2018: 62% with no data, 10% decreased T, 12% adulterated

00:04:04 Austin: contamination is real: Cushing's syndrome case from practice

00:05:00 "Does it contain the actual pharmaceutical?" — the red flag question

00:05:50 D-aspartic acid: the testosterone booster that lowers testosterone

00:06:12 ZMA / Victor Conte / Balco — the only positive study came from a convicted steroid distributor

00:06:55 BALCO sidebar — podcast, ESPN, Barry Bonds

00:07:55 Austin: when a patient comes in on a booster — safety first, then goals

00:08:52 Jordan: patient anecdote — intern year, performance-motivated patient

Next Steps

Check out our new book, Signal (coming soon)

For evidence-based resistance training programs: barbellmedicine.com/training-programs

For individualized training consultation: barbellmedicine.com/coaching

Explore our full library of articles on health and performance: barbellmedicine.com/resources

To consult with Drs. Baraki or Feigenbaum email us at [e-mail]

To support us and get ad free listening, plus special product discounts, and exclusive content, go to supercast.barbellmedicine.com

Resources

Clemesha, C.G., et al. (2020). "Testosterone Boosting" Supplements Composition and Claims Are Not Supported by the Academic Literature. World J Men's Health, 38(1), 115–122. — 62% no published data, 10% decreased T.

Tucker, J., et al. (2018). Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US FDA Warnings. JAMA Network Open, 1(6), e183337. — 12% adulterated with undisclosed steroids.

Prasad AS, Mantzoros CS, Beck FW, Hess JW, Brewer GJ. Zinc status and serum testosterone levels of healthy adults. Nutrition. 1996 May;12(5):344-8. doi: 10.1016/s0899-9007(96)80058-x. PMID: 8875519.

Wilborn CD, Kerksick CM, Campbell BI, Taylor LW, Marcello BM, Rasmussen CJ, Greenwood MC, Almada A, Kreider RB. Effects of Zinc Magnesium Aspartate (ZMA) Supplementation on Training Adaptations and Markers of Anabolism and Catabolism. J Int Soc Sports Nutr. 2004 Dec 31;1(2):12-20. doi: 10.1186/1550-2783-1-2-12. PMID: 18500945; PMCID: PMC2129161.

Maggio M, Ceda GP, Lauretani F, Cattabiani C, Avantaggiato E, Morganti S, Ablondi F, Bandinelli S, Dominguez LJ, Barbagallo M, Paolisso G, Semba RD, Ferrucci L. Magnesium and anabolic hormones in older men. Int J Androl. 2011 Dec;34(6 Pt 2):e594-600. doi: 10.1111/j.1365-2605.2011.01193.x. Epub 2011 Jun 15. PMID: 21675994; PMCID: PMC4623306.

Topo E, Soricelli A, D'Aniello A, Ronsini S, D'Aniello G. The role and molecular mechanism of D-aspartic acid in the release and synthesis of LH and testosterone in humans and rats. Reprod Biol Endocrinol. 2009 Oct 27;7:120. doi: 10.1186/1477-7827-7-120. PMID: 19860889; PMCID: PMC2774316.

Melville GW, Siegler JC, Marshall PW. Three and six grams supplementation of d-aspartic acid in resistance trained men. J Int Soc Sports Nutr. 2015 Apr 1;12:15. doi: 10.1186/s12970-015-0078-7. PMID: 25844073; PMCID: PMC4384294.